Progenra, Inc.'s Novel USP7 Inhibitors are Shown to Exert Multiple Anti-Tumor Effects
10/8/2012 10:09:45 AM
More...
|
New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells
9/17/2012 9:34:11 AM
More...
|
New Study Demonstrating the Selectivity of Progenra, Inc.'s Novel Anti-Tumor Compound
11/28/2011 10:09:26 AM
More...
|
Progenra, Inc. and Tokyo Medical University Form Rheumatoid Arthritis Research Collaboration
10/24/2011 7:29:41 AM
More...
|
Progenra, Inc. and Ono Pharmaceutical Company, Ltd. Enter into Research Collaboration
10/11/2011 11:13:01 AM
More...
|
Progenra, Inc. Receives Approval of Novel Patent for Isopeptidase High Throughput Screening Platform
7/26/2010 12:34:45 PM
More...
|
LifeSensors Inc. Launches their Ubiquitin Pathway Enzymes Assay Kits Licensed from Progenra, Inc.
7/10/2009 8:53:13 AM
More...
|